# Montreal Immune-Related Adverse Events (MIRAE) Study

> **NCT05139706** · — · RECRUITING · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Cancer
- Immune System Disorder
- Inflammatory Reaction
- Autoimmune Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05139706
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-21
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05139706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05139706, "Montreal Immune-Related Adverse Events (MIRAE) Study". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05139706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*